PTX 2.44% 4.2¢ prescient therapeutics limited

"One patient in 500mg/m2 cohort has multi-chemorefractory PTCL...

  1. 113 Posts.
    lightbulb Created with Sketch. 4
    "One patient in 500mg/m2 cohort has multi-chemorefractory PTCL and is stable while and the other patient, who has cutaneous T cell lymphoma (CTCL) and achieved a partial response (PR). Both of these patients have received 9 cycles of PTX-100 treatment."

    great news!
 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.